STOCK TITAN

Twist Bioscience restricted shares vest; 9,724 shares slated for sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience (TWST) filed a Form 144 reporting a proposed sale of 9,724 common shares with an aggregate market value of $312,986.38, to be sold through Fidelity Brokerage Services LLC on 10/06/2025 on NASDAQ. The shares were acquired on 10/01/2025 through restricted stock vesting and were paid as compensation.

The filing also discloses prior sales by the same person, Paula Green, totaling 3,201 shares sold across five trades between 08/04/2025 and 10/02/2025, generating $86,859.32 in gross proceeds. The company-wide share count reported in the notice is 60,360,925 shares outstanding. The filer certifies no undisclosed material adverse information.

Positive

  • Restricted stock vesting shows use of equity to compensate employees, aligning pay with company ownership
  • Brokered sale via Fidelity uses an established brokerage channel, suggesting standard execution

Negative

  • Planned sale of 9,724 shares (aggregate $312,986.38) will increase share supply on 10/06/2025
  • Insider sold 3,201 shares for $86,859.32 in the prior three months, indicating ongoing monetization of holdings

Insights

TL;DR: An insider sale after recent restricted stock vesting increases available shares but appears routine.

The transaction shows 9,724 shares vesting on 10/01/2025 and a planned sale on 10/06/2025 through Fidelity, with an aggregate market value of $312,986.38. That links compensation vesting directly to immediate disposition of shares rather than long-term holding.

The seller previously sold 3,201 shares for $86,859.32 between 08/04/2025 and 10/02/2025, indicating repeated monetization of equity. Monitor near-term volume on NASDAQ around 10/06/2025 and any disclosed trading-plan dates to assess whether sales follow a structured plan or ad-hoc decisions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What is TWST filing in this Form 144?

The filing reports a proposed sale of 9,724 common shares worth $312,986.38 to be sold on 10/06/2025 on NASDAQ through Fidelity Brokerage Services.

How were the 9,724 TWST shares acquired?

The shares were acquired on 10/01/2025 via restricted stock vesting and paid as compensation.

Has the filer sold TWST shares recently?

Yes. Paula Green sold 3,201 shares across five trades from 08/04/2025 to 10/02/2025, receiving $86,859.32 in gross proceeds.

How many TWST shares are outstanding according to the filing?

The filing lists 60,360,925 shares outstanding.

Through which broker will the proposed TWST sale be executed?

The broker named is Fidelity Brokerage Services LLC (address shown in the filing).